Navigating diagnostic and treatment decisions in non‐small cell lung cancer: expert commentary on the multidisciplinary team approach

S Popat, N Navani, KM Kerr, EF Smit… - The …, 2021 - academic.oup.com
Non‐small cell lung cancer (NSCLC) accounts for approximately one in five cancer‐related
deaths, and management requires increasingly complex decision making by health care …

Pneumocystis jiroveci pneumonia: a review of management in human immunodeficiency virus (HIV) and non-HIV immunocompromised patients

A Ibrahim, A Chattaraj, Q Iqbal, A Anjum… - Avicenna Journal of …, 2023 - thieme-connect.com
Pneumocystis jirovecii pneumonia is an opportunistic fungal infection that was mainly
associated with pneumonia in patients with advanced human immunodeficiency virus (HIV) …

[HTML][HTML] Radiotherapy-related lymphopenia affects overall survival in patients with lung cancer

A Abravan, C Faivre-Finn, J Kennedy… - Journal of Thoracic …, 2020 - Elsevier
Introduction Lymphopenia after radiotherapy has an adverse effect on the patient's outcome.
However, the relationship between radiotherapy dose delivery and lymphopenia is not fully …

[HTML][HTML] A single-center, person-month-based analysis of the risk of developing Pneumocystis pneumonia (PCP) in immunosuppressed non-HIV patients: Preventive …

K Miyake, T Kawamura, Y Nakahara… - Journal of Infection and …, 2023 - Elsevier
Objective We performed a retrospective study to evaluate the risk factors for acquiring
Pneumocystis pneumonia (PCP) by pharmacologically immunosuppressed HIV-negative …

Insights into potential pathogenesis and treatment options for immune-checkpoint inhibitor-related pneumonitis

H Ando, K Suzuki, T Yanagihara - Biomedicines, 2021 - mdpi.com
Immune-checkpoint inhibitors (ICIs) targeting cytotoxic T-lymphocyte antigen 4 (CTLA-4),
programmed cell death-1 (PD-1), and programmed cell death-1-ligand 1 (PD-L1) have …

Aetiology and prognostic risk factors of mortality in patients with pneumonia receiving glucocorticoids alone or glucocorticoids and other immunosuppressants: a …

L Li, SH Hsu, X Gu, S Jiang, L Shang, G Sun, L Sun… - BMJ open, 2020 - bmjopen.bmj.com
Objectives Long-term use of high-dose glucocorticoids can lead to severe
immunosuppression and increased risk of treatment-resistant pneumonia and mortality. We …

Clinical characteristics and risk factors associated with Pneumocystis jirovecii infection in patients with solid tumors: study of thirteen-year medical records of a large …

K Takeda, S Harada, B Hayama, K Hoashi, T Enokida… - BMC cancer, 2021 - Springer
Background Pneumocystis jirovecii pneumonia (PCP)-related risk factors among patients
with solid tumors are not completely defined. Thus, we aimed to characterize PCP cases …

Pneumocystis jirovecii pneumonia associated with immune checkpoint inhibitors: a systematic literature review of published case reports and disproportionality …

S Xia, H Gong, Y Wang, L Liu, Y Zhao, L Guo… - Frontiers in …, 2023 - frontiersin.org
Background: Pneumocystis jirovecii pneumonia (PJP) has been reported with ICIs but
limited to case reports. The clinical features of PJP with ICIs remain mostly unknown. This …

[HTML][HTML] Immune biomarkers in the peripheral blood and tumor microenvironment of classical hodgkin lymphoma patients in relation to tumor burden and response to …

TA Mulder, ML Andersson, L Peña-Pérez… - …, 2022 - journals.lww.com
In classical Hodgkin lymphoma (cHL), the malignant cells represent only a small fraction of
the tumor. Yet, they orchestrate a lymphocyte-dominated tumor microenvironment (TME) that …

[HTML][HTML] Radiotherapy-related lymphopenia in patients with advanced non-small cell lung cancer receiving palliative radiotherapy

A Abravan, HA Eide, Å Helland, E Malinen - Clinical and translational …, 2020 - Elsevier
Background Lymphopenia during radiotherapy (RT) may have an adverse effect on
treatment outcome. The aim of this study is to investigate associations between lymphopenia …